Compare SVRA & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVRA | UPBD |
|---|---|---|
| Founded | 2007 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2009 | 1996 |
| Metric | SVRA | UPBD |
|---|---|---|
| Price | $5.38 | $19.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $7.33 | ★ $32.25 |
| AVG Volume (30 Days) | ★ 1.4M | 758.7K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | N/A | ★ $4,695,061,000.00 |
| Revenue This Year | N/A | $5.96 |
| Revenue Next Year | $430.87 | $6.47 |
| P/E Ratio | ★ N/A | $19.02 |
| Revenue Growth | N/A | ★ 8.67 |
| 52 Week Low | $3.34 | $15.82 |
| 52 Week High | $7.01 | $28.03 |
| Indicator | SVRA | UPBD |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 42.07 |
| Support Level | $5.14 | $18.44 |
| Resistance Level | $5.43 | $19.51 |
| Average True Range (ATR) | 0.19 | 0.55 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 18.63 | 38.95 |
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions, Mexico segment offers lease-to-own stores in Mexico. The The Brigit segment offers various financial health products and tools to help users improve their financial health. The company derives a majority of its revenue from the Acima segment.